Skip to main content
. 2022 May 23;11(10):1517. doi: 10.3390/foods11101517

Figure 2.

Figure 2

Combinatorial effect of SBO and Docetaxel (DTX) on cell viability of NSCLC. Dose-response curves of (a) A549 and (b) H23 cells treated with SBO and DTX at indicated concentrations, either alone or in combination, for 24 h.